GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Panacos Pharmaceuticals Inc (GREY:PANC) » Definitions » Total Liabilities

PANC (Panacos Pharmaceuticals) Total Liabilities : $24.47 Mil (As of Sep. 2008)


View and export this data going back to 1998. Start your Free Trial

What is Panacos Pharmaceuticals Total Liabilities?

Panacos Pharmaceuticals's Total Liabilities for the quarter that ended in Sep. 2008 was $24.47 Mil.

Panacos Pharmaceuticals's quarterly Total Liabilities increased from Mar. 2008 ($25.87 Mil) to Jun. 2008 ($26.48 Mil) but then declined from Jun. 2008 ($26.48 Mil) to Sep. 2008 ($24.47 Mil).

Panacos Pharmaceuticals's annual Total Liabilities increased from Dec. 2005 ($5.97 Mil) to Dec. 2006 ($6.97 Mil) and increased from Dec. 2006 ($6.97 Mil) to Dec. 2007 ($26.84 Mil).


Panacos Pharmaceuticals Total Liabilities Historical Data

The historical data trend for Panacos Pharmaceuticals's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Panacos Pharmaceuticals Total Liabilities Chart

Panacos Pharmaceuticals Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.41 32.78 5.97 6.97 26.84

Panacos Pharmaceuticals Quarterly Data
Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.48 26.84 25.87 26.48 24.47

Panacos Pharmaceuticals Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Panacos Pharmaceuticals's Total Liabilities for the fiscal year that ended in Dec. 2007 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=9.704+(16.535+0.601
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=26.84

Total Liabilities=Total Assets (A: Dec. 2007 )-Total Equity (A: Dec. 2007 )
=55.71-28.87
=26.84

Panacos Pharmaceuticals's Total Liabilities for the quarter that ended in Sep. 2008 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=12.817+(11.152+0.497
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=24.47

Total Liabilities=Total Assets (Q: Sep. 2008 )-Total Equity (Q: Sep. 2008 )
=29.738-5.272
=24.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Panacos Pharmaceuticals Total Liabilities Related Terms

Thank you for viewing the detailed overview of Panacos Pharmaceuticals's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Panacos Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
134 Coolidge Avenue, Watertown, MA, USA, 02472
Panacos Pharmaceuticals Inc is a biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other human viral diseases.

Panacos Pharmaceuticals Headlines

No Headlines